Gastrointestinal pathogens employ a variety of mechanisms to damage host tissue, acquire nutrients, and evade treatment. To supplement broad-spectrum antimicrobials, there has been increasing interest in designing molecules that target specific taxa virulence processes. Excitingly, these antivirulence therapies may be able synthesized by gut-resident microbes, thereby enabling delivery drugs di...